文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

急性肾损伤与肠道菌群的关联:整合孟德尔随机化与真实世界临床队列的研究

[Association of acute kidney injury with gut microbiota: a study integrating Mendelian randomization and real-world clinical cohort].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2026-01-01
一句话结论孟德尔随机化提示急性肾损伤遗传易感性与柯林斯菌属等丰度降低相关,真实世界ICU队列显示急性肾损伤患者肠道菌群以促炎菌富集、共生菌耗竭为特征。

该研究整合孟德尔随机化与真实世界ICU前瞻性队列,探讨急性肾损伤与肠道菌群的关联。孟德尔随机化分析显示急性肾损伤遗传易感性与柯林斯菌属、罗斯氏菌属等6个菌属丰度降低及1个菌属丰度增加相关。临床队列纳入94例ICU患者(急性肾损伤组72例、非急性肾损伤组22例),16S rDNA测序显示两组肠道菌群组成存在显著差异,急性肾损伤组链球菌属等促炎菌相对富集。作者认为柯林斯菌属可能作为急性肾损伤的潜在生物标志物。

要点

  • 孟德尔随机化显示急性肾损伤遗传易感性与柯林斯菌属丰度降低相关(β=-0.144,P=0.029)。
  • ICU队列中急性肾损伤组较非急性肾损伤组除血肌酐更高外,其他基线临床特征无统计学显著差异。
  • 急性肾损伤组肠道菌群中链球菌属等促炎菌相对富集,而柯林斯菌属等共生菌相对丰度显著降低。
  • LEfSe分析识别韦荣球菌属未分类等为急性肾损伤组潜在生物标志物,另3个菌属更倾向非急性肾损伤组特征。
  • 作者认为柯林斯菌属可能作为急性肾损伤的潜在生物标志物。

适用人群与场景

  • 临床队列连续纳入2024年12月至2025年3月青岛市市立医院ICU收治的成人患者,根据ICU期间是否发生急性肾损伤分为急性肾损伤组与非急性肾损伤组。
  • 最终分析94例,其中急性肾损伤组72例、非急性肾损伤组22例;初始纳入129例,排除临床数据不完整25例及样本16S rDNA基因扩增不足无法测序10例。
  • 孟德尔随机化分析使用FinnGen联盟急性肾损伤全基因组关联研究数据集与荷兰微生物组计划肠道菌群组成全基因组关联研究数据集。

诊断标准与关键阈值

  • 急性肾损伤诊断依据2012年改善全球肾脏病预后组织(KDIGO)临床实践指南标准。
  • 基线临床数据收集于ICU入科48小时内,包括性别、年龄、身高、体重、体重指数、主要合并症、生命体征、血肌酐、血常规、C反应蛋白、白介素-6等。
  • 肛拭子采集于ICU入科48小时内,用于16S rDNA高通量测序。

研究设计与关键结果

  • 孟德尔随机化采用两样本单向分析,主要方法为逆方差加权法,Cochran Q检验无异质性,MR-Egger截距检验无多效性,留一法验证结果稳健。
  • 属水平:急性肾损伤遗传易感性与柯林斯菌属丰度降低(β=-0.144,P=0.029)、Lachnospiraceaenoname丰度降低(β=-0.131,P=0.040)、罗斯氏菌属丰度降低(β=-0.126,P=0.047)、Parasutterella丰度降低(β=-0.198,P=0.023)相关。
  • 种水平:急性肾损伤遗传易感性与Parasutterellaexcrementihominis丰度降低(β=-0.197,P=0.024)、罗斯氏菌属未分类丰度降低(β=-0.280,P=0.012)相关,与Bacteroidesintestinalis丰度增加相关(β=0.358,P=0.013)。
  • 临床队列16S rDNA高通量测序获得6 868 647条高质量序列,聚类为13 025个扩增子序列变体。
  • 种水平显著差异分析:急性肾损伤组较非急性肾损伤组链球菌属(Streptococcus anginosus)和Novosphingobium sp. B0.09-8相对富集;而未培养普雷沃菌属、Alistipesshahii、未培养粪球菌属、柯林斯菌属(Collinsellatanakaei)、Streptococcus equinus、Alistipesindistinctus、Klebsiellasp. GRB36和未培养颤螺菌属相对丰度显著降低。
  • LEfSe分析:韦荣球菌属未分类、Ligilactobacillus未分类、Collinsellatanakaei、Atopobium未分类和Streptococcus anginosus为急性肾损伤组潜在生物标志物;Alistipesshahii、未培养普雷沃菌属和Agathobacter未分类更倾向非急性肾损伤组特征。
  • 急性肾损伤组血肌酐高于非急性肾损伤组,其他基线临床特征两组间无统计学显著差异。

证据类型、等级与局限

  • 研究类型为孟德尔随机化分析联合单中心前瞻性临床队列研究。
  • 孟德尔随机化分析中Cochran Q检验无异质性、MR-Egger截距检验无多效性、留一法验证结果稳健。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为急性肾损伤的发生影响肠道菌群谱,特征为柯林斯菌属丰度降低。
  • 作者认为急性肾损伤患者肠道菌群以促炎菌富集和共生菌耗竭为特征。
  • 作者认为柯林斯菌属可能作为急性肾损伤的潜在生物标志物。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the association between acute kidney injury (AKI) and the gut microbiota by integrating 16S sequencing analysis with mendelian randomization (MR).

METHODS: 1) MR analysis: The genome-wide association study (GWAS) dataset for AKI from the FinnGen consortium and the GWAS dataset for gut microbiota composition from the Dutch Microbiome Project were selected to screen single nucleotide polymorphism (SNP) associated with AKI as instrumental variable (IV) for genetic variation, using AKI as the exposure factor. Potential causal associations between AKI and gut microbiota were analyzed using a two-sample, one-way MR analysis with the primary analysis method of inverse variance weighted (IVW). Heterogeneity analysis was performed using the Cochran Q test. Potential pleiotropy was assessed using the MR-Egger intercept test. Sensitivity analysis was performed using the leave-one-out test. 2) Clinical cohort study: Consecutive patients admitted to the intensive care unit (ICU) of Qingdao Municipal Hospital between December 2024 and March 2025 were prospectively enrolled. Patients were classified into the AKI group or the non-AKI group based on the occurrence of AKI during their ICU stay, according to the diagnostic criteria from Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guidelines (2012). Baseline clinical data were collected within 48 hours of ICU admission, including gender, age, height, weight, body mass index (BMI), major comorbidities, vital signs, serum creatinine (SCr), blood routine, C-reactive protein (CRP), interleukin-6 (IL-6), etc. Anal swabs were collected from patients within 48 hours of ICU admission for 16S rDNA high-throughput sequencing. Significant difference analysis and linear discriminant analysis effect size (LEfSe) were performed to characterize the gut microbiota profile in AKI patients and to further validate the findings from the MR analysis.

RESULTS: 1) MR analysis results: Using the GWAS summary statistics for gut microbiota and AKI, the MR analysis revealed that the genetic liability to AKI was associated with decreased abundance in six gut microbial taxa and increased abundance in one taxon. IVW analysis showed that at the genus level, genetic susceptibility to AKI was associated with lower abundance of Collinsella (β=-0.144, P=0.029), Lachnospiraceaenoname (β=-0.131, P=0.040), Roseburia (β=-0.126, P=0.047), and Parasutterella (β=-0.198, P=0.023). At the species level, AKI genetic susceptibility was linked to reduced abundance of Parasutterellaexcrementihominis (β=-0.197, P=0.024) and Roseburia unclassified (β=-0.280, P=0.012), while being associated with increased abundance of Bacteroidesintestinalis (β=0.358, P=0.013). Cochran Q test showed no heterogeneity, MR-Egger intercept test revealed no pleiotropy, and leave-one-out analysis verified the robustness of the results. 2) Clinical cohort study results: A total of 129 patients were initially enrolled. After excluding 25 patients with incomplete clinical data and 10 whose samples failed to generate sufficient 16S rDNA gene amplification for sequencing, 94 patients were included in the final analysis comprising 72 cases in the AKI group and 22 cases in the non-AKI group. Apart from higher SCr levels in the AKI group than those in the non-AKI group, no statistically significant differences were observed in other baseline clinical characteristics between the two groups. 16S rDNA high-throughput sequencing yielded 6 868 647 high-quality reads, which were clustered into 13 025 amplicon sequence variant (ASV). Significant difference analysis at the species level showed that, compared with the non-AKI group, patients in the AKI group had a relative enrichment of Streptococcus anginosus and Novosphingobium sp. B0.09-8. Conversely, the relative abundances of uncultured Prevotellasp., Alistipesshahii, uncultured Coprococcussp., Collinsellatanakaei, Streptococcus equinus, Alistipesindistinctus, Klebsiellasp. GRB36, and uncultured Oscillospirasp. were significantly lower in the AKI group. LEfSe analysis identified Veillonella unclassified, Ligilactobacillus unclassified, Collinsellatanakaei, Atopobium unclassified, and Streptococcus anginosus as potential biomarkers for the AKI group, whereas Alistipesshahii, uncultured Prevotella sp., and Agathobacter unclassified were more characteristic of the patients in the non-AKI group.

CONCLUSIONS: The MR analysis suggests that the occurrence of AKI exerts an influence on the gut microbiota profile, characterized by a reduction in the abundance of the genus Collinsella. Findings from the real-world study further indicate significant differences in gut microbiota composition between patients with and without AKI. Overall, the gut microbiota of AKI patients is characterized by an enrichment of pro-inflammatory bacteria and a depletion of commensal symbionts. The genus Collinsellamay may serve as a potential biomarker for AKI.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Li J, Lian Z, Wang Y, et al. [Association of acute kidney injury with gut microbiota: a study integrating Mendelian randomization and real-world clinical cohort]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 42200243. doi:10.3760/cma.j.cn121430-20250903-00472

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。